Financial insights of ACH

MyFinsight

Income Overview

Revenue
$613,234K
Net Income
-$89,070K
Net Profit Margin
-14.52%
EPS
-$1.16
Unit: Thousand (K) dollars
Revenue Breakdown
Diabetes Product
Sleep Therapy Product
Home Respiratory Therapy Product
Others
Revenue Breakdown
Commercial Payors
Medicare
Medicaid

Income Statement	2026-06-30	2026-03-31	2025-12-31
Net revenue	613,234	627,780	690,508*
Cost of net revenue	349,827	349,752	368,183*
Selling, general and administrative expenses	243,560	255,226	266,890*
Transaction breakage fee	-	-	20,000*
Acquisition-related charges and intangible amortization	29,229	29,229	23,958*
Exit and realignment charges, net	25,768	-23,552	4,612*
Total operating costs and expenses	648,384	610,655	683,643*
Operating loss	-35,150	17,125	6,865*
Interest expense, net	-34,539	32,348	26,796*
Transaction financing fees, net	-	-	4,572*
Loss on modification and extinguishment of debt	-17,296	-	-
Other expense, net	-643	-1,023	-985*
Loss from continuing operations before income taxes	-87,628	-16,246	-25,488*
Income tax provision (benefit)	1,442	-9,778	182*
Loss from continuing operations, net of tax	-89,070	-6,468	-25,670*
Net revenue	-	-	1,977,414*
Cost of goods sold	-	-	1,781,286*
Gross profit	-	-	196,128*
Distribution, selling, and administrative expenses	-	-	195,697*
Acquisition-related charges and intangible amortization	-	-	3,137*
Exit and realignment charges, net	-	-	18,095*
Goodwill impairment charge	-	-	26,597*
Loss on classification to held for sale	-	-	199,732*
Other operating expense, net	-	-	-2,733*
Operating (loss) income	-	-	-249,864*
Interest expense, net	-	-	-9,000*
Other expense	-	-	351*
Loss from discontinued operations before income taxes	-	-	-259,216*
Income tax benefit for discontinued operations	-	-	-9,727*
Loss from discontinued operations, net of tax	-	-	-249,489*
Net loss	-89,070	-6,468	-275,160

Basic EPS	-1.16	-0.08	-3.578
Diluted EPS	-1.16	-0.08	-3.578
Basic Average Shares	76,695,000	76,432,000	76,897,000
Diluted Average Shares	76,695,000	76,432,000	76,897,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

MyFinsight

Income Overview

Revenue
$613,234K
Net Income
-$89,070K
Net Profit Margin
-14.52%
EPS
-$1.16
Unit: Thousand (K) dollars
Revenue Breakdown
Diabetes Product
Sleep Therapy Product
Home Respiratory Therapy Product
Others
Revenue Breakdown
Commercial Payors
Medicare
Medicaid

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Income Overview

Revenue
$613,234K
Net Income
-$89,070K
Net Profit Margin
-14.52%
EPS
-$1.16
Unit: Thousand (K) dollars
Revenue Breakdown
Diabetes Product
Sleep Therapy Product
Home Respiratory Therapy Product
Others
Revenue Breakdown
Commercial Payors
Medicare
Medicaid

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Income Overview

Revenue$613,234KNet Income-$89,070KNet Profit Margin-14.52%EPS-$1.16Unit: Thousand (K) dollarsRevenue BreakdownDiabetes ProductSleep Therapy ProductHome Respiratory Therapy ProductOthersRevenue BreakdownCommercial PayorsMedicareMedicaid

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Income Overview

Revenue$613,234KNet Income-$89,070KNet Profit Margin-14.52%EPS-$1.16Unit: Thousand (K) dollarsRevenue BreakdownDiabetes ProductSleep Therapy ProductHome Respiratory Therapy ProductOthersRevenue BreakdownCommercial PayorsMedicareMedicaid

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Revenue
$613,234K
Net Income
-$89,070K
Net Profit Margin
-14.52%
EPS
-$1.16
Unit: Thousand (K) dollars
Revenue Breakdown
Diabetes Product
Sleep Therapy Product
Home Respiratory Therapy Product
Others
Revenue Breakdown
Commercial Payors
Medicare
Medicaid

Revenue
$613,234K
Net Income
-$89,070K
Net Profit Margin
-14.52%
EPS
-$1.16
Unit: Thousand (K) dollars
Revenue Breakdown
Diabetes Product
Sleep Therapy Product
Home Respiratory Therapy Product
Others
Revenue Breakdown
Commercial Payors
Medicare
Medicaid